FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981728148> ?p ?o ?g. }

• W1981728148 endingPage "290" @default.
• W1981728148 startingPage "281" @default.
• W1981728148 abstract "Background: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system. Riboflavin is involved in myelin formation in nerve cells. Riboflavin is a precursor of flavin adenine D-nucleotide (FAD), which is a coenzyme of methylene tetrahydrofolate reductase (MTHFR), which is an important enzyme for remethylation of homocysteine. Riboflavin supplementation has been shown to affect the serum levels of homocysteine in healthy volunteers. The aim of the present study was to test the effect of riboflavin supplementation on the status and disability of patients with MS and whether this effect could be mediated by serum homocysteine levels. Materials and Methods: This was a randomized, double-blind, controlled trial in which 29 MS patients with a mean age of 33 were tested with riboflavin, and the placebo group, with a mean age of 31, received either riboflavin supplementation (10 mg) or the placebo daily for six months. Disability, measured by the Expanded Disability Status Scale (EDSS) scores, erythrocyte glutathione reductase activity coefficient (EGRAC), and serum homocysteine levels were measured before and after the study. Results: The mean ± SD of EDSS score was significantly decreased in both groups over the six months of the study (2.3 ± 0.7 vs. 1.6 ± 0.6 for the riboflavin group and 2.8 ± 1.1 vs. 2.3 ± 1.3 for the placebo groups. The comparison across both groups yielded a non-significant change (P = 0.001 and 0.02, respectively). No significant differences were observed between the two groups in terms of EGRAC, riboflavin deficiency levels by EGRAC category, and serum homocysteine levels before and after the study. Conclusion: Riboflavin supplementation (10 mg/day) to patients with MS does not improve disability status. It appears that this effect is not related to serum homocysteine levels." @default.
• W1981728148 created "2016-06-24" @default.
• W1981728148 creator A5002994360 @default.
• W1981728148 creator A5009008659 @default.
• W1981728148 creator A5013218005 @default.
• W1981728148 creator A5021599299 @default.
• W1981728148 creator A5030177573 @default.
• W1981728148 creator A5082131467 @default.
• W1981728148 creator A5090717799 @default.
• W1981728148 date "2013-10-01" @default.
• W1981728148 modified "2023-10-11" @default.
• W1981728148 title "Riboflavin Supplementation to Patients with Multiple Sclerosis does not Improve Disability Status nor is Riboflavin Supplementation Correlated to Homocysteine" @default.
• W1981728148 doi "https://doi.org/10.1024/0300-9831/a000170" @default.
• W1981728148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25305223" @default.
• W1981728148 hasPublicationYear "2013" @default.
• W1981728148 type Work @default.
• W1981728148 sameAs 1981728148 @default.
• W1981728148 citedByCount "18" @default.
• W1981728148 countsByYear W19817281482014 @default.
• W1981728148 countsByYear W19817281482015 @default.
• W1981728148 countsByYear W19817281482016 @default.
• W1981728148 countsByYear W19817281482017 @default.
• W1981728148 countsByYear W19817281482018 @default.
• W1981728148 countsByYear W19817281482019 @default.
• W1981728148 countsByYear W19817281482020 @default.
• W1981728148 countsByYear W19817281482021 @default.
• W1981728148 countsByYear W19817281482022 @default.
• W1981728148 countsByYear W19817281482023 @default.
• W1981728148 crossrefType "journal-article" @default.
• W1981728148 hasAuthorship W1981728148A5002994360 @default.
• W1981728148 hasAuthorship W1981728148A5009008659 @default.
• W1981728148 hasAuthorship W1981728148A5013218005 @default.
• W1981728148 hasAuthorship W1981728148A5021599299 @default.
• W1981728148 hasAuthorship W1981728148A5030177573 @default.
• W1981728148 hasAuthorship W1981728148A5082131467 @default.
• W1981728148 hasAuthorship W1981728148A5090717799 @default.
• W1981728148 hasConcept C104317684 @default.
• W1981728148 hasConcept C126322002 @default.
• W1981728148 hasConcept C134018914 @default.
• W1981728148 hasConcept C135763542 @default.
• W1981728148 hasConcept C142724271 @default.
• W1981728148 hasConcept C165069038 @default.
• W1981728148 hasConcept C181199279 @default.
• W1981728148 hasConcept C185592680 @default.
• W1981728148 hasConcept C197957613 @default.
• W1981728148 hasConcept C203014093 @default.
• W1981728148 hasConcept C204787440 @default.
• W1981728148 hasConcept C27081682 @default.
• W1981728148 hasConcept C2775859393 @default.
• W1981728148 hasConcept C2776155809 @default.
• W1981728148 hasConcept C2777090595 @default.
• W1981728148 hasConcept C2778760513 @default.
• W1981728148 hasConcept C2780640218 @default.
• W1981728148 hasConcept C33093398 @default.
• W1981728148 hasConcept C43563269 @default.
• W1981728148 hasConcept C538909803 @default.
• W1981728148 hasConcept C55493867 @default.
• W1981728148 hasConcept C71924100 @default.
• W1981728148 hasConceptScore W1981728148C104317684 @default.
• W1981728148 hasConceptScore W1981728148C126322002 @default.
• W1981728148 hasConceptScore W1981728148C134018914 @default.
• W1981728148 hasConceptScore W1981728148C135763542 @default.
• W1981728148 hasConceptScore W1981728148C142724271 @default.
• W1981728148 hasConceptScore W1981728148C165069038 @default.
• W1981728148 hasConceptScore W1981728148C181199279 @default.
• W1981728148 hasConceptScore W1981728148C185592680 @default.
• W1981728148 hasConceptScore W1981728148C197957613 @default.
• W1981728148 hasConceptScore W1981728148C203014093 @default.
• W1981728148 hasConceptScore W1981728148C204787440 @default.
• W1981728148 hasConceptScore W1981728148C27081682 @default.
• W1981728148 hasConceptScore W1981728148C2775859393 @default.
• W1981728148 hasConceptScore W1981728148C2776155809 @default.
• W1981728148 hasConceptScore W1981728148C2777090595 @default.
• W1981728148 hasConceptScore W1981728148C2778760513 @default.
• W1981728148 hasConceptScore W1981728148C2780640218 @default.
• W1981728148 hasConceptScore W1981728148C33093398 @default.
• W1981728148 hasConceptScore W1981728148C43563269 @default.
• W1981728148 hasConceptScore W1981728148C538909803 @default.
• W1981728148 hasConceptScore W1981728148C55493867 @default.
• W1981728148 hasConceptScore W1981728148C71924100 @default.
• W1981728148 hasIssue "5" @default.
• W1981728148 hasLocation W19817281481 @default.
• W1981728148 hasLocation W19817281482 @default.
• W1981728148 hasOpenAccess W1981728148 @default.
• W1981728148 hasPrimaryLocation W19817281481 @default.
• W1981728148 hasRelatedWork W1536030564 @default.
• W1981728148 hasRelatedWork W1537451857 @default.
• W1981728148 hasRelatedWork W1582973519 @default.
• W1981728148 hasRelatedWork W1977687891 @default.
• W1981728148 hasRelatedWork W2003455778 @default.
• W1981728148 hasRelatedWork W2014786452 @default.
• W1981728148 hasRelatedWork W2158198978 @default.
• W1981728148 hasRelatedWork W2238618881 @default.
• W1981728148 hasRelatedWork W2397427716 @default.
• W1981728148 hasRelatedWork W30620141 @default.
• W1981728148 hasVolume "83" @default.
• W1981728148 isParatext "false" @default.
• W1981728148 isRetracted "false" @default.

• next